About Jeff Jonas
Form D filings for RYNE Biotechnology in 2024 list Jeff Jonas as director.
Jeff Jonas first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Jeff Jonas in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jeff Jonas works with at each company, as listed on that company's latest Form D.
RYNE Biotechnology Inc. · Form D, Mar 1, 2024
JG
Jeff Goater
Director
PF
Peter Fuhrken
Director
HF
Howard Federoff
Executive officer and director
NM
Nick Manusos
CEO and director
DF
David Fallace
Director
MO
Martin Ostrowski
Executive officer
JY
Jonathan Yeh
Director